Allegiant Reports October 2024 Traffic
Get Alerts ALGT Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
Revenue Growth %: +7.0%
Join SI Premium – FREE
"As observed below and consistent with commentary from our third quarter earnings call, hurricanes Helene and Milton had an outsized impact on our business," stated
Scheduled Service – Year Over Year Comparison | |||
Change | |||
Passengers | 1,168,344 | 1,407,936 | (17.0 %) |
Revenue passenger miles (000) | 1,059,877 | 1,257,473 | (15.7 %) |
Available seat miles (000) | 1,349,511 | 1,502,611 | (10.2 %) |
Load factor | 78.5 % | 83.7 % | (5.2pts) |
Departures | 8,679 | 9,716 | (10.7 %) |
Average stage length (miles) | 887 | 873 | 1.6 % |
Total System* – Year Over Year Comparison | |||
Change | |||
Passengers | 1,197,186 | 1,442,874 | (17.0 %) |
Available seat miles (000) | 1,428,955 | 1,573,859 | (9.2 %) |
Departures | 9,311 | 10,336 | (9.9 %) |
Average stage length (miles) | 875 | 859 | 1.8 % |
*Total system includes scheduled service and fixed fee contract. System revenue passenger miles and system load |
Preliminary Financial Results | |
$ per gallon | |
Allegiant Travel Company
ALGT/G
Note: This news release was accurate at the date of issuance. However, information contained in the release may have changed. If you plan to use the information contained herein for any purpose, verification of its continued accuracy is your responsibility.
For further information please visit the company's investor website: ir.allegiantair.com
Reference to the Company's website above does not constitute incorporation of any of the information thereon into this news release.
Allegiant Media Contact: | Investor Inquiries: | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/allegiant-reports-october-2024-traffic-302306826.html
SOURCE Allegiant Travel Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- PureHealth Research Utilizes Bioavailable Cranberry and Astragalus in Premium Natural Supplements for Kidney Health
- SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share